S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
The Financial Day of Reckoning Has Begun (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Myanmar executions revive pressure for more sanctions
3 Stocks Set to Lead the Nasdaq Bull Market
Stocks higher on Wall Street; economic worries hit oil price
126% Average Gains While Stocks Crash (Ad)pixel
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
The Financial Day of Reckoning Has Begun (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Myanmar executions revive pressure for more sanctions
3 Stocks Set to Lead the Nasdaq Bull Market
Stocks higher on Wall Street; economic worries hit oil price
126% Average Gains While Stocks Crash (Ad)pixel
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
The Financial Day of Reckoning Has Begun (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Myanmar executions revive pressure for more sanctions
3 Stocks Set to Lead the Nasdaq Bull Market
Stocks higher on Wall Street; economic worries hit oil price
126% Average Gains While Stocks Crash (Ad)pixel
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
The Financial Day of Reckoning Has Begun (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Myanmar executions revive pressure for more sanctions
3 Stocks Set to Lead the Nasdaq Bull Market
Stocks higher on Wall Street; economic worries hit oil price
126% Average Gains While Stocks Crash (Ad)pixel
NASDAQ:HSDT

Helius Medical Technologies - HSDT Short Interest Ratio & Short Volume

$0.53
-0.02 (-3.61%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.50
$0.57
50-Day Range
$0.48
$2.02
52-Week Range
$0.45
$15.68
Volume
6.69 million shs
Average Volume
1.23 million shs
Market Capitalization
$2.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.00

Helius Medical Technologies Short Interest Data

Current Short Volume
173,600 shares
Previous Short Volume
59,300 shares
Change Vs. Previous Month
+192.75%
Dollar Volume Sold Short
$148,132.88
Short Interest Ratio / Days to Cover
0.1
Last Record Date
July, 31 2022
Outstanding Shares
3,798,000 shares
Percentage of Shares Shorted
4.57%
Today's Trading Volume
6,692,280 shares
Average Trading Volume
1,230,852 shares
Today's Volume Vs. Average
443.71%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Helius Medical Technologies ?

Sign up to receive the latest short interest report for Helius Medical Technologies and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

HSDT Short Interest Over Time

HSDT Days to Cover Over Time

HSDT Percentage of Float Shorted Over Time


Helius Medical Technologies (NASDAQ:HSDT) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/2022173,600 shares $148,132.88 +192.8%N/A0.1 $0.85
7/15/202259,300 shares $63,451.00 +958.9%N/A0.1 $1.07
6/30/20225,600 shares $6,608.00 -88.8%N/A0 $1.18
6/15/202250,100 shares $73,647.00 +276.7%N/A0.1 $1.47
5/31/202213,300 shares $19,418.00 +9.9%N/A0 $1.46
5/15/202212,100 shares $19,360.00 -15.4%N/A0.5 $1.60
4/30/202214,300 shares $44,187.00 -31.9%N/A0.9 $3.09
4/15/202221,000 shares $65,312.10 +32.9%N/A1.4 $3.11
3/31/202215,800 shares $52,298.00 -15.1%N/A1 $3.31
3/15/202218,600 shares $57,660.00 -11.9%N/A1.1 $3.10
2/28/202221,100 shares $97,904.00 +9.3%N/A1.2 $4.64
2/15/202219,300 shares $84,148.00 -17.9%N/A1 $4.36
1/31/202223,500 shares $92,590.00 -39.6%N/A0.8 $3.94
1/15/202238,900 shares $197,223.00 +15.4%N/A0 $5.07
12/31/202133,700 shares $174,903.00 +37.0%N/A1.3 $5.19
12/15/202124,600 shares $135,300.00 +3.8%N/A1 $5.50
11/30/202123,700 shares $160,686.00 -44.4%N/A1.1 $6.78
11/15/202142,600 shares $348,468.00 -35.2%N/A2.2 $8.18
10/29/202165,700 shares $930,969.00 -2.1%3.3%2.9 $14.17
10/15/202167,100 shares $968,253.00 -4.3%3.3%3.1 $14.43
9/30/202170,100 shares $1.01 million -11.4%3.5%3.2 $14.40
9/15/202179,100 shares $1.14 million -4.8%3.9%3.7 $14.41
8/31/202183,100 shares $1.20 million +3.1%N/A3.8 $14.40
8/13/202180,600 shares $1.14 million -5.1%3.9%3.5 $14.11
7/30/202184,900 shares $1.31 million -6.0%4.3%6.9 $15.39
7/15/202190,300 shares $1.48 million -7.3%4.6%5.6 $16.36
6/30/202197,400 shares $1.65 million +16.4%4.9%5.3 $16.99
6/15/202183,700 shares $1.22 million -5.4%4.3%1.4 $14.52
5/28/202188,500 shares $1.18 million -3.1%4.5%1.4 $13.36
5/14/202191,300 shares $1.31 million -12.2%4.6%1.4 $14.35
4/30/2021104,000 shares $1.79 million -7.3%5.3%1.4 $17.24
4/15/2021112,200 shares $1.97 million -23.5%5.7%1.2 $17.56
3/31/2021146,700 shares $2.53 million +407.6%7.5%1.5 $17.25
3/15/202128,900 shares $409,802.00 -7.7%1.5%0.3 $14.18
2/26/202131,300 shares $431,940.00 +31.5%1.7%0.3 $13.80
2/12/202123,800 shares $339,626.00 -79.3%1.3%0.2 $14.27
1/29/2021115,200 shares $1.53 million +62.5%6.2%1.3 $13.31
1/15/202170,900 shares $1.09 million -93.1%5.6%1 $15.41
12/31/20201,020,000 shares $427,380.00 +13.1%85.7%17.1 $0.42
12/15/2020902,000 shares $365,310.00 +1.4%N/A4.7 $0.41
11/30/2020889,300 shares $354,474.98 +0.0%N/A6 $0.40
11/15/2020888,900 shares $346,671.00 -1.4%N/A5.8 $0.39
10/30/2020901,400 shares $360,469.86 +4.6%N/A4.9 $0.40
10/15/2020862,000 shares $394,365.00 -10.3%N/A3.6 $0.46
9/30/2020960,700 shares $371,694.83 +5.6%N/A2.4 $0.39
9/15/2020910,000 shares $13.71 million -7.1%N/A1.9 $15.07













HSDT Short Interest - Frequently Asked Questions

What is Helius Medical Technologies' current short interest?

Short interest is the volume of Helius Medical Technologies shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 173,600 shares of HSDT short. Learn More on Helius Medical Technologies' current short interest.

Is Helius Medical Technologies' short interest increasing or decreasing?

Helius Medical Technologies saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 173,600 shares, an increase of 192.7% from the previous total of 59,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Helius Medical Technologies' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Helius Medical Technologies: Nuwellis, Inc. (0.13%), Kiora Pharmaceuticals, Inc. (0.47%), SciSparc Ltd. (3.02%), Vallon Pharmaceuticals, Inc. (0.71%), ThermoGenesis Holdings, Inc. (1.14%), Agile Therapeutics, Inc. (3.61%), China SXT Pharmaceuticals, Inc. (1.01%), First Wave BioPharma, Inc. (3.99%), Quoin Pharmaceuticals, Ltd. (9.30%), and AnPac Bio-Medical Science Co., Ltd. (0.62%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: KLA Co. ($2.87 billion), Lucid Group, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.08 billion), Coinbase Global, Inc. ($1.91 billion), Williams-Sonoma, Inc. ($1.85 billion), Chesapeake Energy Co. ($1.81 billion), Rivian Automotive, Inc. ($1.64 billion), Lumen Technologies, Inc. ($1.61 billion), Plug Power Inc. ($1.50 billion), and Generac Holdings Inc. ($1.49 billion). View all of the most shorted stocks.

What does it mean to sell short Helius Medical Technologies stock?

Short selling HSDT is an investing strategy that aims to generate trading profit from Helius Medical Technologies as its price is falling. HSDT shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Helius Medical Technologies?

A short squeeze for Helius Medical Technologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HSDT, which in turn drives the price of the stock up even further.

How often is Helius Medical Technologies' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HSDT, twice per month. The most recent reporting period available is July, 31 2022.



This page (NASDAQ:HSDT) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.